v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Selling, general and administrative $ 7,051,468 $ 7,878,596
Research and development 7,198,494 8,100,765
Loss from operations (14,249,962) (15,979,361)
Other income (expense):    
Change in fair value of warrant liabilities (77,806) 56,245
Interest and dividends, net 423,184 415,368
Other income, net 345,378 471,613
Loss before income taxes (13,904,584) (15,507,748)
Provision for income taxes
Net loss from continuing operations (13,904,584) (15,507,748)
Net loss from discontinued operations, net of tax (453,910)
Net loss $ (13,904,584) $ (15,961,658)
Weighted-average common shares outstanding, basic (in Shares) 1,096,082 1,226,600
Weighted-average common shares outstanding, diluted (in Shares) 1,096,082 1,226,600
Basic loss per share from continuing operations (in Dollars per share) $ (12.69) $ (12.64)
Diluted loss per share from continuing operations (in Dollars per share) (12.69) (12.64)
Basic loss per share from discontinuing operations (in Dollars per share) (0.37)
Diluted loss per share from discontinuing operations (in Dollars per share) $ (0.37)
Comprehensive loss:    
Net loss $ (13,904,584) $ (15,961,658)
Foreign currency translation (2,519) (3,991)
Comprehensive loss $ (13,907,103) $ (15,965,649)

Source